Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Partnering With Jooble

Advertising

The Latest Pharma Jobs, News and Events

pharmiweb.com today | 23 January 2017

Werfen And Instrumentation Laboratory Acquire Accriva Diagnostics, Expanding Leadership In Point-Of-Care Testing

Werfen and its subsidiary Instrumentation Laboratory (IL) today announced the acquisition of Accriva Diagnostics, a global leader in in vitro diagnostic (IVD) blood testing at the Point-of-Care (POC), including its flagship product portfolio spanning coagulation, platelet aggregation, CO-Oximetry and incision devices.  This acquisition will allow IL to establish a market-leading position in hospital-based POC Hemostasis testing, expand its position in POC Critical Care testing, and complement its leadership of the Hemostasis laboratory segment. ...

"Over the course of our 50-year history, we have demonstrated our strong commitment to expanding our IVD business through organic growth, complemented with highly strategic acquisitions," said Carlos Pascual, CEO at Werfen.  "Like our recent acquisition of CA Casyso AG and its Tem subsidiaries, the acquisition of Accriva is exemplary of this commitment, as well as the confidence we have in our future together." 

An integral part of Werfen, IL develops and manufactures Hemostasis, Critical Care and Patient Blood Management (PBM) products.  Key Accriva product additions to the Company's portfolio include Hemochron, the gold standard for Activated Clotting Time (ACT) testing, and VerifyNow, the leading system for platelet function analysis, among other leading brands. These products are primarily used at the POC during interventional cardiac and vascular procedures, and in hospital laboratories.

"By acquiring Accriva, we are expanding our product offering, expertise, and know-how in Point-of-Care testing, particularly for Hemostasis," said Ramon Benet, CEO at IL.  "The addition of Accriva products to our strong Critical Care, Hemostasis and Patient Blood Management portfolios creates an even more comprehensive and integrated testing solution for hospital acute care settings and laboratories, further impacting positive clinical outcomes and reducing healthcare costs."

show more
Advertising

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.